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Science, technology and innovation have been identified as key 
drivers of economic growth for South Africa (SA).[1] In particular, 
genetic and genomic research are seen as important for developing 
a strong bio-economy,[2] with the potential to improve population 
health and to drive job creation.[3] Open science and sharing of 
access to biological samples and data are key features of genomic 
research and have been recognised by the Department of Science and 
Technology (DST) as an important element of the Fourth Industrial 
Revolution.[4] 
SA researchers share access to SA genomic data within SA, across 
Africa and with other international collaborators as an essential part 
of finding solutions to healthcare problems. The benefits of data 
sharing include the optimal use of resources, increased statistical 
power, more reproducible science, promotion of new research on 
existing data sets and fostering of innovation.[5] Yet, the true value 
of data can be unlocked if governance frameworks are in place to 
enable the legal and ethical sharing of and access to genomic data 
in a manner that does not cause harm to participants and promotes 
public trust. 
There has been an unquestionable shift towards the strengthening 
of data protection laws worldwide. The European Union, Japan, 
Argentina, Morocco and India, to name just a few jurisdictions, 
have either introduced significant personal information protection 
regulatory instruments or are in the midst of strengthening existing 
ones. In line with these international legal developments, SA has 
introduced its first comprehensive legislative framework on data 
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Genomic research has been identified in South Africa (SA) as important in developing a strong bio-economy that has the potential to 
improve human health, drive job creation and offer potential solutions to the disease burden harboured by low- and middle-income 
countries. Central to the success of genomic research is the wide sharing of biological samples and data, but the true value of data can only 
be unlocked if there are laws and policies in place that foster the legal and ethical sharing of genomic data. The introduction and entry into 
force of SA’s Protection of Personal Information Act (POPIA) No. 4 of 2013 is to be welcomed, but the wording of POPIA as it pertains to 
consent for the processing of personal information for research purposes has sparked a debate about the legal status of broad consent. We 
argue that a purposive interpretation of the legislation would permit broad consent for the processing of personal information for research. 
Although there are ongoing debates surrounding the ethical use of broad consent in Africa, the objective of this article is not to engage with 
the ethics of broad consent itself, but rather to focus on the legal status of broad consent for genomic data sharing under POPIA.
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protection: the Protection of Personal Information Act (POPIA) 
No. 4 of 2013. Two key questions that must be addressed before this 
legislation comes into force in 2020, however, are the legal status of 
genomic research and of broad consent under POPIA. 
This article considers each of these questions in turn and in 
particular focuses on broad consent. Broad consent is defined in the 
National Department of Health (DoH) Ethics in Health Research 
Guidelines as ‘the donor permits use of the specimen for current 
research, for storage and possible future research purposes, even 
though the precise nature of future research may be unclear at 
present’.[6] While not explicitly addressed in POPIA, we argue that 
a purposive interpretation of this Act would permit broad consent 
for the processing of personal information for research purposes. 
Such an interpretation would align POPIA with other instruments 
that govern genomic research in SA, as well as government policy 
and strategy in this arena. We recognise the ongoing ethical debates 
surrounding the use of broad consent in Africa, but this article does 
not engage with the ethics of broad consent itself. Rather, the focus is 
on the legal status of broad consent under POPIA. Equally, this article 
does not suggest that broad consent must necessarily be adopted in 
any given research study. As per the DoH Guidelines, we argue that 
broad consent should be viewed as one consent process, in addition to 
specific consent or tiered consent, which is legally permissible in SA.
Protection of Personal Information Act
POPIA is the first comprehensive statutory framework for SA that 
explicitly protects personal information.The scope of the law covers 
all sectors and gives full effect to the right to protection of personal 
information, a distinct element of the right to privacy protected 
under section 14 of the Constitution of South Africa. POPIA requires 
that any processing of personal information must satisfy the 
following 8 conditions: (i) accountability; (ii) processing limitation; 
(iii) purpose specification; (iv) further processing limitation; 
(v) information quality; (vi) openness; (vii) security safeguards; and 
(viii) data subject participation. Section 1 of POPIA broadly defines 
the key term of ‘processing’. As a result, processing for the purposes 
of POPIA applies to any treatment of personal information, including 
information that identifies a (living) natural person, thus covering 
genomic data. Processing that falls under POPIA thereby covers the 
collection of genomic data for research purposes and its subsequent 
analysis, storage, modification, use, transmission and erasure. POPIA 
also establishes a new public administrative authority, the Information 
Regulator, to provide guidance and monitor and enforce compliance 
by public and private bodies with POPIA, including universities. 
Overall, the enactment of POPIA is welcomed, as it should serve 
to provide greater guidance for researchers regarding the privacy 
and security safeguards to be implemented and complied with. 
This should serve to advance better transparency, oversight and 
accountability of genomic data research, thereby strengthening public 
trust. As noted by the head of the Information Regulator, chairperson 
Adv. Pansy Tlakula, the appointment of the enforcement arm of 
POPIA is also ‘a significant step in the process of promoting access to 
information as well as protection of personal information’. [7] 
The Act is not yet in effect, but the research community is currently 
preparing for its implementation. This task is made difficult, however, 
because the Act itself does not set out specific rules governing the 
processing of personal information for research purposes. This is 
because POPIA is an omnibus and general framework to govern all 
types of personal information processing by the public and private 
sectors. In other words, the text of POPIA only regulates data sharing 
in genomic research at a high level and not at a sectoral level, and 
therefore tailored guidance on how POPIA applies specifically to the 
processing of genomic data for research is necessary. The general 
framework of POPIA, however, does set out some key starting points 
that will underpin this future guidance. For instance, section 26 
of POPIA imposes a general prohibition on processing of ‘special 
personal information’, which includes biometric data. However, if the 
‘data subject’ consents to processing,[8] or if processing is for ‘research 
purposes’ that serve a public interest or where it would be impossible 
or involve a disproportionate effort to ask for consent,[8] or if the 
Information Regulator has authorised processing with appropriate 
safeguards in place,[8] then the prohibition is lifted. Section 32(5) also 
states that personal information regarding inherited characteristics 
may be processed for research. Thus, under POPIA, genomic data can 
be processed if it is for research purposes. 
Broad consent
Section 13 of POPIA requires personal information to be collected 
for a ‘specific, explicitly defined and lawful purpose’. Within the 
context of genetic research, a strict interpretation would suggest that 
only specific consent is permissible. Adopting this interpretation 
would raise difficulties for many genetic research studies. For 
instance, all research participants for current and ongoing research 
for which broad consent was used would have to be re-contacted and 
re-consented, otherwise the research would have to be terminated. 
This could stifle current and future research and innovation, and 
undermine the objective of a strong bio-economy driving economic 
growth in SA. 
POPIA does envisage situations when the further processing of 
personal information is necessary. Further processing of personal 
information is permitted, provided it is compatible with the original 
purpose for which it was collected (section15(1)). The Act does 
not describe the scope of ‘compatible’, but does detail instances in 
which the processing of personal information for purposes outside 
of the original consent will be permitted. For research purposes they 
include: processing necessary to ‘prevent or mitigate a serious and 
imminent threat to’ public health (section15(3)(d)(i)) or ‘the life or 
health of the data subject or another individual’ (section 15(3)(d)(ii)), 
or if the information is to be used for research purposes and ‘will not 
be published in an identifiable form’ (section15(3)(e)). Secondary 
use of data for purposes beyond the specific consent is therefore 
permitted if the data are to be used for research intended to improve 
health, provided that the information will not be published in an 
identifiable form. This means that demographic information and 
data that a reasonably foreseeable method can use to identify the data 
subject or which can be linked by a reasonably foreseeable method to 
other information that identifies the data subject, must be removed 
(section 1). Herein lies the challenge for genomic research: genomic 
information is inherently identifiable, which seems to suggest that 
specific consent must always be obtained. 
This narrow reading of the Act, however, ignores two fundamental 
elements that underpin POPIA. First, the constitutional right to 
privacy is not absolute and the preamble to POPIA states that it may 
be subject to limitations ‘that are aimed at protecting other rights and 
important interests’. Here, one could make a reasonable argument 
that genomic research constitutes an important public interest in 
SA, and thus necessitating a specific consent model for all research 
studies would undermine the public interest in facilitating genomic 
research. Secondly, POPIA inherently recognises the non-absolute 
nature of the right to privacy through the restrictions that it allows 
for throughout the Act. For instance, section 2 states that the purpose 
of the legislation is to give effect to the constitutional right to privacy 
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by safeguarding personal information, subject to limitations that seek 
to protect ‘important interests, including the free flow of information 
within the Republic and across national borders’. 
Moreover, the responsible party may be exempt from some of 
the strict provisions of POPIA, including restriction on retention 
of records (section 14), duty to notify (section 18), and prohibition 
on processing of special personal information (section 26), when 
processing is for research purposes. POPIA itself thus makes special 
exceptions for research purposes and thereby places importance on 
research and on the sharing of data, both locally and globally. Further, 
special authorisation may be available for medical professionals 
and healthcare institutions to process personal information about 
a person’s health, including inherited characteristics, for research 
purposes.[8] These provisions appear to indicate that processing of 
genomic data can continue for research purposes, which will enable 
the continued flow of genomic data for research within and beyond 
SA.[8] 
POPIA also does not exist in isolation, but is one of a number of 
pre-existing frameworks that govern genomic research. This includes 
the National Health Act No. 61 of 2003 and the 2012 Regulations, the 
Promotion of Access to Information Act 2 of 2000, the 2018 Material 
Transfer Agreement Guidelines and the DoH 2015 Guidelines. 
It is crucial to note that these are sector-specific legally binding 
instruments that permit the use of broad consent for genomic 
research that provide further guidance on the use of broad consent. 
In particular, the DoH Guidelines distinguish broad consent from 
blanket consent (which is not permitted) and require that the ‘nature 
of the further usage should be described as fully as possible and 
should stipulate that further prior ethics review of the new study is 
necessary’. Thus, the use of broad consent under POPIA must adhere 
to the DoH Guidelines. 
Conclusions 
A clear, comprehensive legislative framework to govern use and 
sharing of access to genomic data collected in SA is necessary to 
ensure adequate and effective oversight and governance procedures 
that foster fairness, accountability and trust. Such a framework, 
however, also must align with national research priorities and existing 
legal and ethical frameworks that govern and oversee the use of 
genomic data in SA, as well as with international best practice, so 
that SA continues to contribute to and benefit from research in the 
global arena. To ensure legal certainty and public trust, it is necessary 
that the legal issues surrounding consent are clarified prior to POPIA 
coming into force.
Under section 60 of POPIA, the Information Regulator can 
authorise a code of conduct to govern specific sectors. We suggest 
such a code follow the guidance provided in the DoH 2015 Ethics 
in Health Research Guidelines and the 2018 National Material 
Transfer Agreement Guidelines, including that secondary use of data 
provided through broad consent is subject to ongoing governance 
controls, especially review and monitoring by a registered research 
ethics committee and potentially also a data access committee. 
Participant and community engagement and involvement are also 
crucial components of governance controls to ensure that ongoing 
and proposed research uses are acceptable and fall within the 
reasonable privacy expectations of the relevant community. 
Currently, the Universities South Africa (USAf) is drafting a code 
of conduct for use by universities. It is concerning, however, that the 
draft code seems to focus primarily on handling personal information 
for human resource and student administration purposes and does 
not address research data. To fulfil the vision of developing a strong 
bio-economy that is in part driven by genomic research, SA needs a 
code of conduct that provides clear standardised guidance about the 
requirements and safeguards necessary for research data collection 
and sharing. 
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